Your browser doesn't support javascript.
loading
Human Polo-like Kinase Inhibitors as Antiplasmodials.
Bohmer, Monica J; Wang, Jinhua; Istvan, Eva S; Luth, Madeline R; Collins, Jennifer E; Huttlin, Edward L; Wang, Lushun; Mittal, Nimisha; Hao, Mingfeng; Kwiatkowski, Nicholas P; Gygi, Steven P; Chakrabarti, Ratna; Deng, Xianming; Goldberg, Daniel E; Winzeler, Elizabeth A; Gray, Nathanael S; Chakrabarti, Debopam.
Afiliação
  • Bohmer MJ; Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States.
  • Wang J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Istvan ES; Department of Cancer Biolo gy, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Luth MR; Division of Infectious Diseases, Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
  • Collins JE; Department of Pediatrics, School of Medicine, University California, San Diego, La Jolla, California 92093, United States.
  • Huttlin EL; Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States.
  • Wang L; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Mittal N; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, California 94305, United States.
  • Hao M; Department of Pediatrics, School of Medicine, University California, San Diego, La Jolla, California 92093, United States.
  • Kwiatkowski NP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Gygi SP; Department of Cancer Biolo gy, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Chakrabarti R; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Deng X; Department of Cancer Biolo gy, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Goldberg DE; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Winzeler EA; Division of Cancer Research, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States.
  • Gray NS; School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
  • Chakrabarti D; Division of Infectious Diseases, Department of Medicine and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
ACS Infect Dis ; 9(4): 1004-1021, 2023 04 14.
Article em En | MEDLINE | ID: mdl-36919909
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antimaláricos Limite: Humans Idioma: En Revista: ACS Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antimaláricos Limite: Humans Idioma: En Revista: ACS Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos